FIELD: chemical and pharmaceutical industry, oncology, immunology.
SUBSTANCE: invention relates to correction of cancer-dependent immunodeficit in Pliss lymphosarcoma, namely normalizing of CD4+ T-lymphocyte level in rat peripheral blood by using chorial gonadotropin.
EFFECT: new agent for normalizing of CD4+ T-lymphocyte level in rat peripheral blood.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR INHIBITION OF MITOTIC ACTIVITY OF PLISS'S LYMPHOSARCOMA CELLS | 2004 |
|
RU2263514C1 |
| AGENT FOR INHIBITION OF PLISS'S LYMPHOSARCOMA GROWTH | 2004 |
|
RU2263513C1 |
| METHOD FOR CORRECTION OF CANCER CARRIER LIVER MORPHOLOGICAL STATE | 2004 |
|
RU2271813C1 |
| METHOD OF STIMULATING DYSTROPHIC CHANGES IN TUMOUR TISSUE | 2008 |
|
RU2379070C1 |
| METHOD OF PATHOLOGICAL PROCESS MODULATION AND DISORGANISATION OF CELL CARCINOMA CULTURE OF THROAT Hep-2 | 2007 |
|
RU2349600C1 |
| AGENT FOR TUMOR TISSUE DESTRUCTION AND CORRECTION OF ORGANISM WITH TUMOR ENDOGENOUS INTOXICATION AND METHOD FOR TUMOR TISSUE DESTRUCTION AND CORRECTION OF ORGANISM WITH TUMOR ENDOGENOUS INTOXICATION | 2006 |
|
RU2319486C1 |
| PREPARATION FOR INHIBITING TUMOR GROWTH AND METHOD FOR INHIBITING TUMOR GROWTH IN EXPERIMENT | 2006 |
|
RU2320334C1 |
| ANTITUMOR AGENT | 1998 |
|
RU2145854C1 |
| METHOD FOR INHIBITING PLISS LYMPHOSARCOMA GROWTH EXPERIMENTALLY | 2014 |
|
RU2561294C1 |
| METHOD OF INCREASE OF ANTITUMORAL EFFECT OF CHEMOTHERAPY | 2007 |
|
RU2361590C2 |
